Evaluation of early antioxidant and anti-inflammatory effects of Ecballium elaterium (L.) A. rich balm in rats with imiquimod-induced psoriasis
Frontiers in Pharmacology · 13.07.2026 · 17
DOI: 10.3389/fphar.2026.1876388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 13.07.2026. Verfasst von Djihene Narimene Benmalek und 15 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Microbiology Health and Proteomics, Department of Biology, Faculty of Natural Sciences and Life, Djillali Liabes University o…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Psoriasis is a persistent cutaneous disorder involving an imbalance in immune regulation, oxidative stress, and abnormal epidermal proliferation. This study evaluated the therapeutic efficacy of Ecballium elaterium (EE) balm compared with clobetasol propionate (0.05%) (CLO) in rats with psoriasis-like lesions induced by topical imiquimod (IMQ). A total of twenty-four adult male of the Wistar strain were randomly allocated to four groups comprising: control (healthy rats), IMQ-induced psoriasis, IMQ + EE balm, and IMQ + clobetasol. Psoriasis was induced by topical application of 5% imiquimod. Treatments were administered daily. Disease severity, histological changes, oxidative stress markers, serum tumor necrosis factor-α (TNF-α), and biochemical parameters were evaluated. EE balm markedly improved psoriatic lesions and reduced psoriasis severity scores in imiquimod-treated rats. Biochemical analyses indicated that EE balm produced fewer disturbances in hepatic and lipid parameters than clobetasol, notably by preventing alanine aminotransferase elevation (EE: 62.20 ± 3.09; CLO: 89 ± 6.08) and lowering total cholesterol (EE: 0.47 ± 0.08; CLO: 0.63 ± 0.03). However, serum triglyceride (EE: 0.61 ± 0.03) and creatinine concentrations (EE: 6.03 ± 0.23) remained elevated. Serum TNF-α levels, markedly elevated in imiquimod-treated rats, were significantly reduced following EE balm and clobetasol treatments compared with the IMQ experimental set (p < 0.001). EE balm also mitigated oxidative stress by lowering thiobarbituric acid reactive substances (TBARS) levels in serum and erythrocytes in the IMQ group. It also restored antioxidant activities, including catalase (IMQ: 3.06 ± 0.79; EE: 4.24 ± 0.73), super oxide dismutase (IMQ: 03.17 ± 1.01; EE: 18.24 ± 1.90), glutathione peroxidase (EE: 31.25 ± 4.99). Additionally, glutathione s-transferase activity was improved in serum and erythrocytes (EE: 09.96 ± 2.29), as were reduced glutathione levels (IMQ: 0.0021 ± 0.0007; EE: 0.0042 ± 0.001). In an imiquimod-induced psoriasis rat model, Ecballium elaterium balm reduced disease severity, oxidative stress, and inflammatory markers, with systemic biochemical changes. Despite these promising findings, this research is still in its early stages based on a single preclinical model.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory of Molecular Microbiology Health and Proteomics, Department of Biology, Faculty of Natural Sciences and Life, Djillali Liabes University of Sidi Bel Abbes, Sidi Bel Abbes, Algeria.
- Laboratory of Biotoxicology, Bioremediation and Phytoremediation, Biology Department, Faculty of Natural and Life Sciences, Ahmed Ben Bella University of Oran1, Oran, Algeria.
- Department of Pharmacology, Faculty of Basic Sciences, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh.
- Department of Food Science and Nutrition, College of Sciences, Taif University, Taif, Saudi Arabia.
- Department of Chemistry, College of Science, Taif University, Taif, Saudi Arabia.
- Research Center of Basic Sciences, Engineering and High Altitude, Taif University, Taif, Saudi Arabia.
Zitieren
APA
Benmalek, D. N., El Kadi, F. Z., Benyahia, A., Tusher, M. H., Kharoubi, O., Harir, N., Hemdan, D. I., Sami, R., Alharthi, S., Almehmadi, A., Izmirly, A. M., Alzahrani, S., Al Masoudi, L. M., Hassan, E. A., Alyahyawi, A., & Almasoudi, A. G. (2026). Evaluation of early antioxidant and anti-inflammatory effects of Ecballium elaterium (L.) A. rich balm in rats with imiquimod-induced psoriasis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1876388
Vancouver
Benmalek DN, El Kadi FZ, Benyahia A, Tusher MH, Kharoubi O, Harir N, et al. Evaluation of early antioxidant and anti-inflammatory effects of Ecballium elaterium (L.) A. rich balm in rats with imiquimod-induced psoriasis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1876388
BibTeX
@article{Benmalek2026,
author = {Benmalek, Djihene Narimene and El Kadi, Fatima Zohra and Benyahia, Aicha and Tusher, Mahedi Hassan and Kharoubi, Omar and Harir, Noria and Hemdan, Dalia I and Sami, Rokayya and Alharthi, Sarah and Almehmadi, Awatif and Izmirly, Abdullah M and Alzahrani, Shatha and Al Masoudi, Luluah M and Hassan, Ehssan A and Alyahyawi, Aseel and Almasoudi, Abeer G},
title = {Evaluation of early antioxidant and anti-inflammatory effects of Ecballium elaterium (L.) A. rich balm in rats with imiquimod-induced psoriasis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1876388}
}
EUVIMED